Share Price and Basic Stock Data
Last Updated: December 12, 2025, 6:53 pm
| PEG Ratio | 0.96 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Univastu India Ltd operates in the construction, contracting, and engineering sector, an industry that has seen fluctuating demand and notable shifts in project dynamics. For the fiscal year ending March 2025, the company reported revenues of ₹171 Cr, a significant increase from ₹121 Cr in the previous fiscal year. This upward trajectory appears robust, especially when considering the trailing twelve months (TTM) revenue of ₹154 Cr. The quarterly sales figures reflect a volatile yet promising pattern; for instance, the sales dipped slightly to ₹24.53 Cr in September 2023 but surged to ₹39.25 Cr by March 2024. This suggests that while the company faces short-term challenges, it has the potential for strong recovery, especially in the upcoming quarters. The growing demand for infrastructure development in India could serve as a catalyst for sustained revenue growth, positioning Univastu favorably in the market.
Profitability and Efficiency Metrics
Univastu’s profitability metrics reveal a company that is navigating operational challenges while maintaining a semblance of efficiency. The operating profit margin (OPM) stood at a commendable 24.92% in the latest quarter, reflecting an increase from earlier figures. However, it is worth noting that OPM fluctuated significantly in the past year, dipping to as low as 9.07% in March 2023 before rebounding. The net profit for the latest fiscal year was ₹16 Cr, with an earnings per share (EPS) of ₹8.68, indicating a healthy return to shareholders. The interest coverage ratio (ICR) at 6.81x suggests that the company is managing its debt obligations effectively, which is a positive sign for its financial health. However, the fluctuating profit margins indicate that cost management and pricing strategies will be critical as competition intensifies in the construction sector.
Balance Sheet Strength and Financial Ratios
Analyzing Univastu’s balance sheet reveals a company that is leveraging its assets effectively while maintaining a manageable debt level. As of March 2025, total borrowings were reported at ₹42 Cr, against reserves of ₹75 Cr, indicating a healthy buffer against liabilities. The debt-to-equity ratio stands at 0.43x, which is relatively low, suggesting that the company is not overly reliant on debt financing. This is further supported by the return on capital employed (ROCE) of 27%, which indicates efficient use of capital in generating profits. However, the price-to-book value (P/BV) ratio of 3.19x could suggest that the stock is somewhat overvalued compared to its book value, which may raise concerns for value-oriented investors. In essence, while the balance sheet appears strong, potential investors should remain cautious about valuation metrics in the context of broader market conditions.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Univastu reflects a strong promoter commitment, with promoters holding 67.46% of the equity. This high level of insider ownership can often indicate confidence in the company’s future, although the lack of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) involvement is notable. The public stake has increased to 32.54%, suggesting growing retail interest, which can be a positive indicator for market sentiment. However, the gradual decline in promoter holding from 73.47% in March 2023 to the current level could raise questions about long-term confidence. As the number of shareholders has risen significantly to 7,104, it demonstrates increasing retail participation, which can help stabilize the stock price but may also lead to volatility if sentiment shifts. Overall, the shareholding pattern presents a mixed bag of confidence and caution for potential investors.
Outlook, Risks, and Final Insight
The outlook for Univastu India Ltd appears cautiously optimistic, driven by strong revenue growth and a solid balance sheet. However, the company faces several risks that could impact its performance. The construction sector is often subject to regulatory changes and project delays which can affect cash flows. Moreover, the volatility in profit margins suggests that while the company is currently profitable, maintaining that profitability amid rising costs and competition will be challenging. Investors should also consider the potential impact of economic downturns on infrastructure spending, which could lead to reduced project opportunities. While Univastu shows promise, understanding the cyclical nature of the construction industry and the inherent risks is essential. For investors, the key will be to monitor the company’s ability to sustain growth while managing costs effectively, ensuring that it navigates potential headwinds successfully.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Engineering and Projects Ltd | 52.8 Cr. | 34.2 | 49.9/22.5 | 5.01 | 39.4 | 0.00 % | 20.5 % | 25.9 % | 10.0 |
| Modis Navnirman Ltd | 660 Cr. | 337 | 409/220 | 80.4 | 46.5 | 0.00 % | 12.9 % | 9.88 % | 10.0 |
| Modulex Construction Technologies Ltd | 150 Cr. | 21.7 | 35.7/18.0 | 44.7 | 0.00 % | 2.51 % | 1.54 % | 10.0 | |
| MPDL Ltd | 33.8 Cr. | 45.7 | 92.7/38.0 | 127 | 0.00 % | 2.87 % | 4.16 % | 10.0 | |
| IITL Projects Ltd | 29.0 Cr. | 58.0 | 77.9/47.1 | 2.12 | 0.00 % | 16.6 % | % | 10.0 | |
| Industry Average | 17,246.10 Cr | 246.17 | 77.27 | 138.42 | 0.16% | 16.68% | 21.32% | 21.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.94 | 17.55 | 28.04 | 28.01 | 26.78 | 24.53 | 29.93 | 39.25 | 28.11 | 42.39 | 41.99 | 39.91 | 29.41 |
| Expenses | 10.26 | 13.28 | 22.45 | 25.47 | 23.82 | 20.44 | 25.21 | 30.89 | 23.51 | 33.90 | 34.26 | 32.16 | 22.08 |
| Operating Profit | 2.68 | 4.27 | 5.59 | 2.54 | 2.96 | 4.09 | 4.72 | 8.36 | 4.60 | 8.49 | 7.73 | 7.75 | 7.33 |
| OPM % | 20.71% | 24.33% | 19.94% | 9.07% | 11.05% | 16.67% | 15.77% | 21.30% | 16.36% | 20.03% | 18.41% | 19.42% | 24.92% |
| Other Income | 0.04 | 0.09 | 0.12 | 0.16 | 0.43 | 0.72 | 0.10 | 0.09 | 0.11 | 0.10 | 0.15 | 0.49 | 0.17 |
| Interest | 1.15 | 1.44 | 1.43 | 1.61 | 1.48 | 1.59 | 1.14 | 1.22 | 1.01 | 1.05 | 1.20 | 1.02 | 1.09 |
| Depreciation | 0.23 | 0.22 | 0.22 | 0.22 | 0.23 | 0.33 | 0.28 | 0.40 | 0.28 | 0.29 | 0.40 | 0.41 | 0.41 |
| Profit before tax | 1.34 | 2.70 | 4.06 | 0.87 | 1.68 | 2.89 | 3.40 | 6.83 | 3.42 | 7.25 | 6.28 | 6.81 | 6.00 |
| Tax % | 25.37% | 25.19% | 25.37% | 35.63% | 27.38% | 34.26% | 27.06% | 32.94% | 28.36% | 44.41% | 18.95% | 38.18% | 33.17% |
| Net Profit | 1.01 | 2.02 | 3.02 | 0.56 | 1.22 | 1.90 | 2.49 | 4.58 | 2.45 | 4.05 | 5.08 | 4.22 | 4.01 |
| EPS in Rs | 0.89 | 1.78 | 2.66 | 0.49 | 0.88 | 1.31 | 1.37 | 2.88 | 1.53 | 2.71 | 2.67 | 2.34 | 2.18 |
Last Updated: August 20, 2025, 1:45 am
Below is a detailed analysis of the quarterly data for Univastu India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 29.41 Cr.. The value appears to be declining and may need further review. It has decreased from 39.91 Cr. (Mar 2025) to 29.41 Cr., marking a decrease of 10.50 Cr..
- For Expenses, as of Jun 2025, the value is 22.08 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 32.16 Cr. (Mar 2025) to 22.08 Cr., marking a decrease of 10.08 Cr..
- For Operating Profit, as of Jun 2025, the value is 7.33 Cr.. The value appears to be declining and may need further review. It has decreased from 7.75 Cr. (Mar 2025) to 7.33 Cr., marking a decrease of 0.42 Cr..
- For OPM %, as of Jun 2025, the value is 24.92%. The value appears strong and on an upward trend. It has increased from 19.42% (Mar 2025) to 24.92%, marking an increase of 5.50%.
- For Other Income, as of Jun 2025, the value is 0.17 Cr.. The value appears to be declining and may need further review. It has decreased from 0.49 Cr. (Mar 2025) to 0.17 Cr., marking a decrease of 0.32 Cr..
- For Interest, as of Jun 2025, the value is 1.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.02 Cr. (Mar 2025) to 1.09 Cr., marking an increase of 0.07 Cr..
- For Depreciation, as of Jun 2025, the value is 0.41 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.41 Cr..
- For Profit before tax, as of Jun 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.81 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 0.81 Cr..
- For Tax %, as of Jun 2025, the value is 33.17%. The value appears to be improving (decreasing) as expected. It has decreased from 38.18% (Mar 2025) to 33.17%, marking a decrease of 5.01%.
- For Net Profit, as of Jun 2025, the value is 4.01 Cr.. The value appears to be declining and may need further review. It has decreased from 4.22 Cr. (Mar 2025) to 4.01 Cr., marking a decrease of 0.21 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.18. The value appears to be declining and may need further review. It has decreased from 2.34 (Mar 2025) to 2.18, marking a decrease of 0.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:27 am
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22 | 42 | 82 | 101 | 111 | 51 | 59 | 87 | 121 | 171 | 160 |
| Expenses | 19 | 38 | 75 | 90 | 100 | 30 | 46 | 72 | 101 | 143 | 129 |
| Operating Profit | 3 | 4 | 6 | 11 | 11 | 21 | 13 | 15 | 20 | 28 | 31 |
| OPM % | 13% | 9% | 8% | 11% | 10% | 42% | 22% | 17% | 16% | 17% | 19% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Interest | 2 | 2 | 2 | 4 | 4 | 7 | 5 | 5 | 5 | 4 | 4 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 1 | 2 | 5 | 6 | 6 | 13 | 7 | 9 | 15 | 23 | 26 |
| Tax % | 40% | 28% | 29% | 27% | 25% | 27% | 27% | 26% | 32% | 34% | |
| Net Profit | 1 | 1 | 3 | 5 | 4 | 10 | 5 | 7 | 10 | 16 | 18 |
| EPS in Rs | 1.02 | 0.54 | 0.98 | 1.33 | 1.27 | 2.81 | 1.54 | 1.94 | 2.09 | 2.91 | 3.68 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 200.00% | 66.67% | -20.00% | 150.00% | -50.00% | 40.00% | 42.86% | 60.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 200.00% | -133.33% | -86.67% | 170.00% | -200.00% | 90.00% | 2.86% | 17.14% |
Univastu India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 43% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 26% |
| TTM: | 43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 51% |
| 3 Years: | 49% |
| 1 Year: | 40% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 15% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 10, 2025, 3:36 am
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 4 | 6 | 6 | 11 | 11 | 11 | 11 | 11 | 12 | 12 |
| Reserves | 3 | 2 | 9 | 14 | 12 | 22 | 27 | 34 | 41 | 68 | 75 |
| Borrowings | 6 | 6 | 15 | 27 | 32 | 40 | 37 | 33 | 34 | 35 | 42 |
| Other Liabilities | 12 | 15 | 30 | 44 | 42 | 48 | 36 | 45 | 53 | 72 | 114 |
| Total Liabilities | 21 | 27 | 60 | 90 | 98 | 121 | 112 | 123 | 139 | 188 | 243 |
| Fixed Assets | 1 | 3 | 7 | 12 | 12 | 10 | 9 | 8 | 9 | 13 | 13 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 20 | 23 | 53 | 78 | 86 | 111 | 103 | 114 | 129 | 174 | 229 |
| Total Assets | 21 | 27 | 60 | 90 | 98 | 121 | 112 | 123 | 139 | 188 | 243 |
Below is a detailed analysis of the balance sheet data for Univastu India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Reserves, as of Sep 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Mar 2025) to 75.00 Cr., marking an increase of 7.00 Cr..
- For Borrowings, as of Sep 2025, the value is 42.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 35.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 7.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 114.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 72.00 Cr. (Mar 2025) to 114.00 Cr., marking an increase of 42.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 243.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 188.00 Cr. (Mar 2025) to 243.00 Cr., marking an increase of 55.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 229.00 Cr.. The value appears strong and on an upward trend. It has increased from 174.00 Cr. (Mar 2025) to 229.00 Cr., marking an increase of 55.00 Cr..
- For Total Assets, as of Sep 2025, the value is 243.00 Cr.. The value appears strong and on an upward trend. It has increased from 188.00 Cr. (Mar 2025) to 243.00 Cr., marking an increase of 55.00 Cr..
Notably, the Reserves (75.00 Cr.) exceed the Borrowings (42.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -3.00 | -2.00 | -9.00 | -16.00 | -21.00 | -19.00 | -24.00 | -18.00 | -14.00 | -7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 129 | 81 | 130 | 112 | 43 | 471 | 173 | 77 | 39 | 15 |
| Inventory Days | 210 | 116 | 141 | 274 | 0 | 0 | 0 | 6 | 9 | 4 |
| Days Payable | 194 | 123 | 240 | 295 | 250 | 303 | 129 | |||
| Cash Conversion Cycle | 144 | 74 | 30 | 90 | 43 | 471 | 173 | -168 | -255 | -110 |
| Working Capital Days | 58 | 43 | 53 | 41 | 32 | 255 | 184 | 91 | 77 | 99 |
| ROCE % | 31% | 29% | 28% | 20% | 30% | 17% | 19% | 24% | 27% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.68 | 6.24 | 5.84 | 4.61 | 8.43 |
| Diluted EPS (Rs.) | 8.68 | 6.24 | 5.84 | 4.61 | 8.43 |
| Cash EPS (Rs.) | 14.08 | 9.86 | 6.63 | 5.44 | 10.37 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 66.70 | 47.51 | 39.89 | 34.04 | 29.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 66.70 | 47.51 | 39.89 | 34.04 | 29.43 |
| Revenue From Operations / Share (Rs.) | 142.70 | 106.02 | 76.50 | 51.69 | 45.09 |
| PBDIT / Share (Rs.) | 24.29 | 18.14 | 13.22 | 11.36 | 18.19 |
| PBIT / Share (Rs.) | 23.14 | 17.05 | 12.44 | 10.53 | 16.28 |
| PBT / Share (Rs.) | 19.58 | 12.81 | 7.92 | 6.34 | 11.56 |
| Net Profit / Share (Rs.) | 12.93 | 8.77 | 5.84 | 4.61 | 8.46 |
| NP After MI And SOA / Share (Rs.) | 8.73 | 6.24 | 5.83 | 4.61 | 8.43 |
| PBDIT Margin (%) | 17.02 | 17.11 | 17.28 | 21.97 | 40.33 |
| PBIT Margin (%) | 16.21 | 16.08 | 16.25 | 20.37 | 36.10 |
| PBT Margin (%) | 13.71 | 12.08 | 10.35 | 12.27 | 25.62 |
| Net Profit Margin (%) | 9.06 | 8.27 | 7.63 | 8.92 | 18.75 |
| NP After MI And SOA Margin (%) | 6.11 | 5.88 | 7.62 | 8.91 | 18.70 |
| Return on Networth / Equity (%) | 13.08 | 13.63 | 14.66 | 13.57 | 28.74 |
| Return on Capital Employeed (%) | 26.44 | 29.31 | 24.29 | 20.16 | 31.34 |
| Return On Assets (%) | 5.57 | 5.11 | 5.33 | 4.68 | 7.88 |
| Long Term Debt / Equity (X) | 0.06 | 0.02 | 0.05 | 0.20 | 0.33 |
| Total Debt / Equity (X) | 0.43 | 0.62 | 0.73 | 0.86 | 1.19 |
| Asset Turnover Ratio (%) | 1.05 | 0.91 | 0.73 | 0.50 | 0.46 |
| Current Ratio (X) | 1.73 | 1.49 | 1.47 | 1.77 | 1.63 |
| Quick Ratio (X) | 1.71 | 1.48 | 1.47 | 1.77 | 1.17 |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.43 | 0.30 |
| Interest Coverage Ratio (X) | 6.81 | 4.29 | 2.93 | 2.71 | 3.85 |
| Interest Coverage Ratio (Post Tax) (X) | 4.63 | 3.07 | 2.29 | 2.10 | 2.79 |
| Enterprise Value (Cr.) | 268.58 | 182.49 | 127.18 | 125.37 | 79.24 |
| EV / Net Operating Revenue (X) | 1.65 | 1.51 | 1.46 | 2.13 | 1.55 |
| EV / EBITDA (X) | 9.68 | 8.85 | 8.46 | 9.71 | 3.83 |
| MarketCap / Net Operating Revenue (X) | 1.49 | 1.31 | 1.12 | 1.64 | 0.84 |
| Price / BV (X) | 3.19 | 3.04 | 2.16 | 2.50 | 1.30 |
| Price / Net Operating Revenue (X) | 1.49 | 1.31 | 1.12 | 1.64 | 0.84 |
| EarningsYield | 0.04 | 0.04 | 0.06 | 0.05 | 0.22 |
After reviewing the key financial ratios for Univastu India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.68. This value is within the healthy range. It has increased from 6.24 (Mar 24) to 8.68, marking an increase of 2.44.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.68. This value is within the healthy range. It has increased from 6.24 (Mar 24) to 8.68, marking an increase of 2.44.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.08. This value is within the healthy range. It has increased from 9.86 (Mar 24) to 14.08, marking an increase of 4.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.70. It has increased from 47.51 (Mar 24) to 66.70, marking an increase of 19.19.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.70. It has increased from 47.51 (Mar 24) to 66.70, marking an increase of 19.19.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 142.70. It has increased from 106.02 (Mar 24) to 142.70, marking an increase of 36.68.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 24.29. This value is within the healthy range. It has increased from 18.14 (Mar 24) to 24.29, marking an increase of 6.15.
- For PBIT / Share (Rs.), as of Mar 25, the value is 23.14. This value is within the healthy range. It has increased from 17.05 (Mar 24) to 23.14, marking an increase of 6.09.
- For PBT / Share (Rs.), as of Mar 25, the value is 19.58. This value is within the healthy range. It has increased from 12.81 (Mar 24) to 19.58, marking an increase of 6.77.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.93. This value is within the healthy range. It has increased from 8.77 (Mar 24) to 12.93, marking an increase of 4.16.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.73. This value is within the healthy range. It has increased from 6.24 (Mar 24) to 8.73, marking an increase of 2.49.
- For PBDIT Margin (%), as of Mar 25, the value is 17.02. This value is within the healthy range. It has decreased from 17.11 (Mar 24) to 17.02, marking a decrease of 0.09.
- For PBIT Margin (%), as of Mar 25, the value is 16.21. This value is within the healthy range. It has increased from 16.08 (Mar 24) to 16.21, marking an increase of 0.13.
- For PBT Margin (%), as of Mar 25, the value is 13.71. This value is within the healthy range. It has increased from 12.08 (Mar 24) to 13.71, marking an increase of 1.63.
- For Net Profit Margin (%), as of Mar 25, the value is 9.06. This value is within the healthy range. It has increased from 8.27 (Mar 24) to 9.06, marking an increase of 0.79.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.11. This value is below the healthy minimum of 8. It has increased from 5.88 (Mar 24) to 6.11, marking an increase of 0.23.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.08. This value is below the healthy minimum of 15. It has decreased from 13.63 (Mar 24) to 13.08, marking a decrease of 0.55.
- For Return on Capital Employeed (%), as of Mar 25, the value is 26.44. This value is within the healthy range. It has decreased from 29.31 (Mar 24) to 26.44, marking a decrease of 2.87.
- For Return On Assets (%), as of Mar 25, the value is 5.57. This value is within the healthy range. It has increased from 5.11 (Mar 24) to 5.57, marking an increase of 0.46.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 24) to 0.06, marking an increase of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.43, marking a decrease of 0.19.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.05. It has increased from 0.91 (Mar 24) to 1.05, marking an increase of 0.14.
- For Current Ratio (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.49 (Mar 24) to 1.73, marking an increase of 0.24.
- For Quick Ratio (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has increased from 1.48 (Mar 24) to 1.71, marking an increase of 0.23.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.81. This value is within the healthy range. It has increased from 4.29 (Mar 24) to 6.81, marking an increase of 2.52.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.63. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 4.63, marking an increase of 1.56.
- For Enterprise Value (Cr.), as of Mar 25, the value is 268.58. It has increased from 182.49 (Mar 24) to 268.58, marking an increase of 86.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.65. This value is within the healthy range. It has increased from 1.51 (Mar 24) to 1.65, marking an increase of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 9.68. This value is within the healthy range. It has increased from 8.85 (Mar 24) to 9.68, marking an increase of 0.83.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.49. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 1.49, marking an increase of 0.18.
- For Price / BV (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 3. It has increased from 3.04 (Mar 24) to 3.19, marking an increase of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.49. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 1.49, marking an increase of 0.18.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Univastu India Ltd:
- Net Profit Margin: 9.06%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 26.44% (Industry Average ROCE: 16.68%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.08% (Industry Average ROE: 21.32%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.63
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.71
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18.2 (Industry average Stock P/E: 77.27)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 9.06%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Construction, Contracting & Engineering | Bunglow No 36/B, C.T.S. No 994 & 945 (S.No.117 & 118), Pune Maharashtra 411038 | cs@univastu.com http://www.univastu.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pradeep Khandagale | Chairman & Managing Director |
| Mr. Narendra Bhagatkar | Executive Director |
| Maj. Gen. (Dr.) Vijay Pawar | Independent Director |
| Mr. Ravindra Savant | Independent Director |
| Mr. Dhananjay Barve | Independent Director |
| Mrs. Rajashri Khandagale | Non Executive Director |
FAQ
What is the intrinsic value of Univastu India Ltd?
Univastu India Ltd's intrinsic value (as of 15 December 2025) is 56.79 which is 14.21% lower the current market price of 66.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 238 Cr. market cap, FY2025-2026 high/low of 115/63.0, reserves of ₹75 Cr, and liabilities of 243 Cr.
What is the Market Cap of Univastu India Ltd?
The Market Cap of Univastu India Ltd is 238 Cr..
What is the current Stock Price of Univastu India Ltd as on 15 December 2025?
The current stock price of Univastu India Ltd as on 15 December 2025 is 66.2.
What is the High / Low of Univastu India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Univastu India Ltd stocks is 115/63.0.
What is the Stock P/E of Univastu India Ltd?
The Stock P/E of Univastu India Ltd is 18.2.
What is the Book Value of Univastu India Ltd?
The Book Value of Univastu India Ltd is 24.2.
What is the Dividend Yield of Univastu India Ltd?
The Dividend Yield of Univastu India Ltd is 0.00 %.
What is the ROCE of Univastu India Ltd?
The ROCE of Univastu India Ltd is 26.6 %.
What is the ROE of Univastu India Ltd?
The ROE of Univastu India Ltd is 15.8 %.
What is the Face Value of Univastu India Ltd?
The Face Value of Univastu India Ltd is 10.0.